Med. praxi. 2021;18(3):227

Komentář ke článku Anafylaxe / Med. praxi 2021; 18(2): 92-96

MUDr. Jiří Slíva, Ph.D.
Ústav farmakologie, 3. LF UK, Praha

Published: September 2, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slíva J. Komentář ke článku Anafylaxe / Med. praxi 2021; 18(2): 92-96. Med. praxi. 2021;18(3):227.
Download citation

References

  1. Sheikh A, Shehata YA, Brown SG, et al. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009; 64(2): 204-212. Go to original source... Go to PubMed...
  2. Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010; 10(4): 354-361. Go to original source... Go to PubMed...
  3. Kmietowicz Z. UK trainee doctors are still unsure about how to treat anaphylaxis. BMJ. 2015; 350: h171. doi: 10.1136/bmj.h171. PMID: 25585512. Go to original source... Go to PubMed...
  4. Kanwar M, Irvin CB, Frank JJ, et al. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Ann Emerg Med. 2010; 55(4): 341-344. Go to original source... Go to PubMed...
  5. Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015; 3(1): 76-80. Go to original source... Go to PubMed...
  6. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001; 108(5): 871-873. Go to original source... Go to PubMed...
  7. Worm M, Nguyen D, Rackley R, et al. Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances. Clin Transl Allergy. 2020; 10: 21. Go to original source... Go to PubMed...
  8. Public Assessment Report. Scientific discussion. Emerade (adrenaline tartrate). SE/H/1261/01-03/DC.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.